Table S1.

Demographic characterization by specific choice of OAT

	VKA	Dabigatran	Rivaroxaban
Age (years) Mean ± SD	77.4±8.0	74.2±10.4	78.2±8.6
Female sex	49.0%	48.6%	57.1%
Hypertension	94.9%	91.9%	96.4%
Diabetes mellitus	28.7%	18.0%	33.9%
Prior independence	79.6%	83.8%	78.6%
Prior warfarin use	64.3%	11.7%#,***,$,*	30.4%
Serum creatinine level	1.29±0.9 mg/dL	0.9±0.3 mg/dL#,*	1.0±0.4 mg/dL
Mean ± SD	114.0±80.0 µmol/L	79.6±27 µmol/L	88.4±35.4 µmol/L

Notes: Patient characteristics at discharge.

^#In comparison to VKA;

^$in comparison to rivaroxaban.

^*P<0.05;

^***P<0.001 after Bonferroni correction.

Abbreviations: OAT, oral anticoagulant therapy; SD, standard deviation; VKA, vitamin K antagonists.